Abstract
Tissue engineering (TE) has provided promising strategies for regenerating tissue defects, but few TE approaches have been translated for clinical applications. One major barrier in TE is providing adequate oxygen supply to implanted tissue scaffolds, since oxygen diffusion from surrounding vasculature in vivo is limited to the periphery of the scaffolds. Moreover, oxygen is also an important signaling molecule for controlling stem cell differentiation within TE scaffolds. Various technologies have been developed to increase oxygen delivery in vivo and enhance the effectiveness of TE strategies. Such technologies include hyperbaric oxygen therapy, perfluorocarbon- and hemoglobin-based oxygen carriers, and oxygen-generating, peroxide-based materials. Here, we provide an overview of the underlying mechanisms and how these technologies have been utilized for in vivo TE applications. Emerging technologies and future prospects for oxygen delivery in TE are also discussed to evaluate the progress of this field towards clinical translation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3422-3432 |
| Number of pages | 11 |
| Journal | Journal of Materials Chemistry B |
| Volume | 4 |
| Issue number | 20 |
| DOIs | |
| State | Published - 2016 |
ASJC Scopus subject areas
- General Chemistry
- Biomedical Engineering
- General Materials Science